Accuray Incorporated: updates and filings

ARAYNASDAQHealthcare · Surgical & Medical Instruments & Apparatus

Price

$2.12

November 19, 2026

What Ploutos Investor adds for Accuray

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 17 fiscal years, from FY2010
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 43% since Nov 6, 2026, when the 10-Q these figures come from was filed ($4.40 then, $2.50 on Nov 18, 2026). The figures date from before that move.10-Q
  • The share price was recently adjusted for a split or a spin-off that the company's last filing does not include yet. Market value, P/E, yields and the other figures measured against the price would mix the new shares with the old figures, so we leave them out until the next filing.
  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 77 daysAround Feb 4, 2027 · for Q2 2027

last Nov 4, 2026next Feb 4, 2027

An estimate from when it has reported before, which has been regular. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Aug 27, 2026 latest annualNov 6, 2026 latest quarterly
  • Nov 17, 2026Over-5% holder statement (active) (amendment)
    FormSCHEDULE 13D/A
  • Nov 13, 2026Unregistered sale of shares, change to shareholders' rights, amended articles or bylaws, Regulation FD disclosure
    Form8-K
  • Nov 6, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Nov 4, 2026Other material events
    Form8-K
  • Nov 4, 2026Results of operations, Regulation FD disclosure
    Form8-K
  • Oct 30, 2026Shares registered for employees
    FormS-8
  • Oct 16, 2026Annual report to shareholdersfor the period to Jun 30, 2026
    FormARS
  • Oct 16, 2026Annual meeting proxy statement
    FormDEF 14A
  • Oct 13, 2026Officer or director change
    Form8-K
  • Oct 6, 2026Officer or director change, shareholder vote, other material events
    Form8-K
  • Sep 18, 2026Additional annual meeting material
    FormDEFA14A
  • Sep 11, 2026Filing
    FormEFFECT
  • Sep 9, 2026Shelf registration for future offerings (amendment)
    FormS-3/A
  • Sep 2, 2026Over-5% holder statement (active) (amendment)
    FormSCHEDULE 13D/A
  • Aug 27, 2026Annual reportfor the period to Jun 30, 2026
    Form10-K
  • Aug 24, 2026Annual meeting proxy statement
    FormDEF 14A
  • Aug 21, 2026Shelf registration for future offerings (amendment)
    FormS-3/A
  • Aug 19, 2026Results of operations, Regulation FD disclosure
    Form8-K
  • Aug 12, 2026Preliminary proxy statement
    FormPRE 14A
  • Aug 6, 2026Delisting notice
    Form8-K
  • Aug 5, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jul 31, 2026Shelf registration for future offerings
    FormS-3
  • Jul 29, 2026Material agreement entered, unregistered sale of shares, officer or director change, other material events
    Form8-K
  • Jul 27, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jul 7, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Mar 6, 2002.

The full analysis

What do Accuray's filings show?

The filings are where every one of Accuray's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.